Negotiations Begin Between Bristol-Myers Squibb and ImClone
By Taskin Ahmed
Pharma Deals Review: Vol 2008 Issue 99 (Table of Contents)
Published: 1 Aug-2008
DOI: 10.3833/pdr.v2008.i99.150 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Bristol-Myers Squibb has offered to buy the remaining shares of ImClone for US$4...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018